As an Adjunct Professor, I am privileged to impart knowledge in Business Law and Ethics, a role I approach with a dual commitment to personal excellence and the enrichment of the next generation of professionals. This position not only keeps me intellectually sharp, honing my expertise in the dynamic field of law, but also allows me to ‘pay it forward’ by mentoring students and guiding them through the complex interplay of legal principles and ethical considerations that govern the business world. My teaching philosophy is rooted in the belief that education is a powerful tool for transformation, and I strive to instill in my students the critical thinking skills and moral compass necessary to navigate their future careers with integrity and social responsibility.

As a dedicated Legal Counsel and Senior Licensing Officer at HP Inc., I have been at the forefront of negotiating, drafting, and managing a comprehensive portfolio of licensing agreements, playing a pivotal role in safeguarding the company’s intellectual property rights and the data privacy rights of all stakeholders. My expertise extends to providing strategic counsel to senior management on a spectrum of legal risks, guiding product development trajectories, and formulating robust go-to-market strategies. My contributions have been integral in steering the company through the dynamic legalities of technology commercialization, ensuring compliance, and fostering innovation.

As Legal Counsel specializing in outbound licensing, I was pivotal in orchestrating complex commercial and intellectual property transactions aimed at maximizing revenue through the strategic monetization of HP’s intellectual property assets. My role encompasses the meticulous negotiation, drafting, and execution of commercial and IP agreements, ensuring optimal terms that benefit HP’s business objectives while maintaining compliance with relevant laws and regulations. My efforts have been instrumental in transforming HP’s rich repository of intellectual property into a significant revenue stream, reflecting a deep understanding of the value and potential of these assets.

Initially entrusted with the mission to ignite new business ventures within HP’s Imaging and Printing Group, I embraced the challenge of identifying and cultivating innovative opportunities that aligned with the division’s pioneering spirit. My strategic acumen was further recognized when I was selected to spearhead the development of a comprehensive growth strategy for the Specialty Printing Systems Division. In this leadership role without authority, I created a tiger team and orchestrated a forward-thinking roadmap that not only expanded our market presence but also solidified HP’s reputation as a leader in specialty printing solutions.

As an Intellectual Property Technologist, I was instrumental in charting the course for HP’s patent portfolio strategy, tailored specifically for burgeoning business ventures within the company. My responsibilities included:Strategizing and Articulating: I meticulously defined and communicated the strategic direction for our patent portfolio, ensuring alignment with HP’s long-term business goals and emerging market trends.Analytical Expertise: I conducted comprehensive portfolio analyses, employing state-of-the-art landscape searches and valuation techniques to inform our IP decisions and maintain our competitive edge.Strategic Counsel: I provided expert counsel to nascent HP businesses and a broad spectrum of internal clients, addressing their strategic IP needs and fostering an environment of sustained innovation and growth

In my dual capacity as Corporate Counsel and Secretary, coupled with the role of Vice President of Business Development, I was instrumental in steering the corporation through complex legal landscapes and strategic growth initiatives. My expertise in product counseling was pivotal in navigating the intricacies of intellectual property law, which underpinned the successful negotiation and drafting of license agreements with multiple research institutions. This strategic legal framework laid the foundation for the company’s robust in-bound licensing program, culminating in the rapid development and launch of over 400 innovative products within a remarkable ten-month period. My contributions not only fortified the company’s product portfolio but also established a precedent for excellence in corporate legal strategy and business expansion.

As a Law Clerk, I honed my legal acumen through in-depth research, meticulous drafting, and critical review of various legal documents, including motions, pleadings, and memoranda, specifically within the realms of securities and antitrust litigation. My role involved:Analytical Research: Conducting comprehensive legal research to support case strategies and ensure adherence to the latest legal precedents and regulatory standards.Drafting Precision: Crafting well-argued motions and pleadings that effectively communicated the legal stance of our clients.Document Review: Diligently reviewing memoranda to ensure accuracy, clarity, and persuasive legal argumentation, contributing to the successful navigation of complex litigation matters.

As a Law Clerk, I specialized in the preparation and execution of blue sky filings and the drafting of critical documents for real estate syndicates, including subscription agreements. My responsibilities encompassed:Regulatory Compliance: Ensuring meticulous adherence to securities regulations across various jurisdictions, facilitating smooth and compliant syndicate operations.Document Drafting: Crafting precise and comprehensive subscription agreements, tailoring each to meet the unique needs of the syndicate while protecting investor interests.Due Diligence: Conducting thorough due diligence to support the accuracy and completeness of filings and documentation, thereby upholding the integrity of the investment process

As a seasoned consultant, I delivered comprehensive due diligence and litigation support to a portfolio of prestigious venture funds and law firms, including Brobeck Phleger & Harrison, Lyon & Lyon, Townsend Townsend & Crew, Palomar Ventures, Enterprise Partners Venture Capital, and Timeline Ventures. My expertise facilitated informed investment decisions and strategic legal positioning, leveraging my deep industry knowledge to provide clients with the insights necessary for navigating complex financial landscapes and legal challenges. My role was pivotal in equipping these entities with the meticulous analysis and actionable intelligence essential for their success.

As the strategic manager of the deal flow process for an investor syndicate led by Qualcomm Ventures, I orchestrated the critical introductions between high-potential portfolio ventures poised for Series A funding and discerning venture capitalists in pursuit of high-growth investment opportunities. My role was pivotal in forging these connections, which catalyzed the advancement of innovative startups within the tech ecosystem. Beyond matchmaking, I delivered incisive competitive profiling and comprehensive market analysis, crafting bespoke positioning and market penetration strategies that empowered emerging ventures to carve out their niche and accelerate their trajectory towards industry leadership.

As an early team member (employee #12) of a pioneering biotech startup, I played a pivotal role in our transition from a private entity to a publicly-traded company, celebrated by the successful launch of a groundbreaking semiconductor-based DNA diagnostic device. My contributions were recognized through a well-deserved promotion to Research Scientist, where I spearheaded the development of our second-generation DNA microarray product, achieving key milestones that propelled our technology forward. My expertise in the field was further acknowledged through my significant role as both co-author and corresponding author in the seminal cover article for Nature Biotechnology, titled “Single Nucleotide Polymorphic Discrimination by an Electronic Dot Blot Assay on Semiconductor Microchips,” which was published in 1999 (Volume 17, Pages 365-370). This publication has been instrumental in shaping the landscape of DNA diagnostic technology.”